Continued strong Cresemba® (isavuconazole) sales trigger second sales milestone this year from Pfizer to Basilea of USD 7 million

    NEXT STORY
    Half-year report
    PREV STORY
    ASLAN Pharmaceuticals Announces Closing of US$15 Million Public Offering of American Depositary Shares, Including Full Exercise of Underwriter’s Option to Purchase Additional ADSs
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    LIDDS: NanoZolid® with cutting edge STING agonist becomes a key project for LIDDS in immuno-oncology field

    Single intratumoral injections of a NanoZolid formulated STING agonist has been proven to achieve ...

    author_avatar
    NASDAQ Market News

    Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million

    author_avatar
    NASDAQ Market News

    Guidewires Market is Forecasted to Attain Revenue of $1,126.5 Million By 2023: P&S Market Research

    author_avatar
    NASDAQ Market News